Relating to price transparency for certain prescription drugs; authorizing civil penalties. Requires a drug manufacturer of an expensive drug sold or offered for sale to submit a report to the department for each expensive drug the total research and development costs for the drug and other related costs. Not later than the 60th day before the date a price increase takes effect, a manufacturer shall submit written notice to the department before the manufacturer increases the average wholesale price or wholesale acquisition cost of an expensive drug by more than: (1) the lesser of 10 percent or $2,500 during a 12-month period; or (2) 15 percent cumulatively during any 24-month period, and provide justification for the increase.